{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:35:48Z","timestamp":1790937348467,"version":"4.1.0"},"reference-count":100,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2013,7,10]],"date-time":"2013-07-10T00:00:00Z","timestamp":1373414400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Diseases"],"published-print":{"date-parts":[[2014,9]]},"abstract":"<jats:p>The autoimmune exocrinopathy <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>j\u00f6gren's syndrome (<jats:styled-content style=\"fixed-case\">SS<\/jats:styled-content>) is characterized by mononuclear cell (MNC) infiltrates of exocrine glands and overactivity of <jats:styled-content style=\"fixed-case\">B<\/jats:styled-content> lymphocytes. Although <jats:styled-content style=\"fixed-case\">T<\/jats:styled-content> cells have long been perceived as the prime effectors, increasing evidence indicates that the key role is rather served by <jats:styled-content style=\"fixed-case\">B<\/jats:styled-content> cells. Among related abnormalities are rheumatoid factor (RF), anti\u2010<jats:styled-content style=\"fixed-case\">SSA<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">R<\/jats:styled-content>o, and anti\u2010<jats:styled-content style=\"fixed-case\">SSB<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">L<\/jats:styled-content>a antibodies (<jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>b). Also, supporting this view is our finding of an increase in the number of circulating na\u00efve mature <jats:styled-content style=\"fixed-case\">B<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>m) cells, with a reciprocal decrease in that of memory <jats:styled-content style=\"fixed-case\">B<\/jats:styled-content> cells. Furthermore, a ratio of <jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>m2\u2010plus\u2010<jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>m2\u2032 cells to early <jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>m5\u2010plus\u2010late <jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>m5 above 5 is diagnostic. This variation partly reflects the migration of active memory <jats:styled-content style=\"fixed-case\">B<\/jats:styled-content> cells into the exocrine glands of the patients, as well as into their skin. More recently, the <jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>\u2010cell\u2010activating factor of the <jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content> family (<jats:styled-content style=\"fixed-case\">BAFF<\/jats:styled-content>) has been endorsed with a pivotal role in <jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>\u2010cell survival and hence implicated in the pathogenesis of autoimmunity. In practice, <jats:styled-content style=\"fixed-case\">B<\/jats:styled-content> cells have turned quite attractive as a target for biotherapy. For example, treatment with anti\u2010<jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>20 <jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>b has afforded some benefits in this disease, while <jats:styled-content style=\"fixed-case\">BAFF<\/jats:styled-content> blockers are still on the way, but should expand our armamentarium for treating <jats:styled-content style=\"fixed-case\">SS<\/jats:styled-content>. With such <jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>\u2010cell\u2010directed biotherapies in mind, we delineate herein the distinguishing traits of <jats:styled-content style=\"fixed-case\">B<\/jats:styled-content> lymphocytes in <jats:styled-content style=\"fixed-case\">SS<\/jats:styled-content>.<\/jats:p>","DOI":"10.1111\/odi.12153","type":"journal-article","created":{"date-parts":[[2013,6,25]],"date-time":"2013-06-25T07:28:40Z","timestamp":1372145320000},"page":"529-537","source":"Crossref","is-referenced-by-count":17,"title":["Are the <scp>B<\/scp> cells cast with the leading part in the <scp>S<\/scp>jogren's syndrome scenario?"],"prefix":"10.1111","volume":"20","author":[{"given":"J\u2010O","family":"Pers","sequence":"first","affiliation":[{"name":"EA2216, Research Unit of Immunopathology University of Brest Brest France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Youinou","sequence":"additional","affiliation":[{"name":"EA2216, Research Unit of Immunopathology University of Brest Brest France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,7,10]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2010.07.005"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.2001.00970.x"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-0172(96)80019-9"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V63.6.1424.1424"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21478"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3181b76ab5"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.2000.00685.x"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203306071871"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0896-8411(91)90016-6"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.096172"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.46.2.123"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.2001.00989.x"},{"key":"e_1_2_10_14_1","first-page":"1256","article-title":"Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis","volume":"35","author":"Bosello S","year":"2008","journal-title":"J Rheumatol"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.152.1.229"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2009.10.004"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni1083"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar1855"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2012.05.014"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.37698"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21936"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22458"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2007.01.010"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.083865"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22536"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.27509"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1988.tb02867.x"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200636270"},{"key":"e_1_2_10_29_1","first-page":"195","article-title":"Factors controlling immunoglobulin production and B cell proliferation","volume":"78","author":"Friedman WH","year":"1991","journal-title":"Bull Cancer"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-007-8028-z"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.029694"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI0214121"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2012.01.016"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2012.05.012"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1999.00778.x"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.10445"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20276"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21129"},{"issue":"3","key":"e_1_2_10_39_1","first-page":"204","article-title":"Peripheral CD27+\u00a0IgD+\u00a0IgM+ B cells in patients with primary Sj\u00f6gren's syndrome and healthy donors","volume":"68","author":"Hansen A","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-08-2694"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1313.002"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.10.6790"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni1552"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20289"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.10221"},{"key":"e_1_2_10_46_1","first-page":"2044","article-title":"Serological implications of germinal center\u2010like structures in primary Sjogren's syndrome","volume":"34","author":"Jonsson MV","year":"2007","journal-title":"J Rheumatol"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1079-2104(05)80307-5"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-89-6-888"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2009.129940"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0803588"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(04)00079-2"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri844"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.190.11.1697"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.2.168"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri1957"},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.1993.tb00487.x"},{"key":"e_1_2_10_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.27314"},{"key":"e_1_2_10_58_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2002.01869.x"},{"key":"e_1_2_10_59_1","doi-asserted-by":"publisher","DOI":"10.1006\/clin.1994.1123"},{"key":"e_1_2_10_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(79)91110-0"},{"key":"e_1_2_10_61_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.10.5970"},{"key":"e_1_2_10_62_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780371006"},{"key":"e_1_2_10_63_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0801859"},{"key":"e_1_2_10_64_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.1.329"},{"key":"e_1_2_10_65_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21205"},{"key":"e_1_2_10_66_1","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1313.004"},{"key":"e_1_2_10_67_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22603"},{"key":"e_1_2_10_68_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21260"},{"key":"e_1_2_10_69_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh407"},{"key":"e_1_2_10_70_1","doi-asserted-by":"publisher","DOI":"10.1038\/416094a"},{"key":"e_1_2_10_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2010.06.014"},{"key":"e_1_2_10_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(03)00111-0"},{"key":"e_1_2_10_73_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.11311"},{"key":"e_1_2_10_74_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.11.1747"},{"key":"e_1_2_10_75_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.057919"},{"key":"e_1_2_10_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(03)00025-6"},{"key":"e_1_2_10_77_1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.berh.2004.03.007","article-title":"Laboratory testing in autoimmune rheumatic diseases","volume":"18","author":"Sheldon J","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"e_1_2_10_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2008.10.006"},{"key":"e_1_2_10_79_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21591"},{"key":"e_1_2_10_80_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj004"},{"key":"e_1_2_10_81_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1990.tb00810.x"},{"key":"e_1_2_10_82_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI3234"},{"key":"e_1_2_10_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-0172(98)80040-1"},{"key":"e_1_2_10_84_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0300-9475.2004.01432.x"},{"key":"e_1_2_10_85_1","first-page":"17","article-title":"Immunopathology of Sjogren's syndrome","volume":"149","author":"Tapinos NI","year":"1998","journal-title":"Ann Med Interne (Paris)"},{"key":"e_1_2_10_86_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.041186"},{"key":"e_1_2_10_87_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.144782"},{"key":"e_1_2_10_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2004.05.010"},{"key":"e_1_2_10_89_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.27611"},{"key":"e_1_2_10_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2007.09.001"},{"key":"e_1_2_10_91_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780390508"},{"key":"e_1_2_10_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)60461-2"},{"key":"e_1_2_10_93_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.6.554"},{"key":"e_1_2_10_94_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199908)42:8<1765::AID-ANR28>3.0.CO;2-V"},{"key":"e_1_2_10_95_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200535134"},{"key":"e_1_2_10_96_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1999.01037.x"},{"key":"e_1_2_10_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2009.02.013"},{"key":"e_1_2_10_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/0896-8411(88)90025-X"},{"key":"e_1_2_10_99_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24665"},{"key":"e_1_2_10_100_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.27564"},{"key":"e_1_2_10_101_1","doi-asserted-by":"publisher","DOI":"10.2174\/138920112802273100"}],"container-title":["Oral Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fodi.12153","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/odi.12153","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T16:39:14Z","timestamp":1695487154000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/odi.12153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,10]]},"references-count":100,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["10.1111\/odi.12153"],"URL":"https:\/\/doi.org\/10.1111\/odi.12153","archive":["Portico"],"relation":{},"ISSN":["1354-523X","1601-0825"],"issn-type":[{"value":"1354-523X","type":"print"},{"value":"1601-0825","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,10]]}}}